Next Article in Journal
Microbial Transformations of 7-Methoxyflavanone
Next Article in Special Issue
Antiprotozoal Activity of Quinonemethide Triterpenes from Maytenus ilicifolia (Celastraceae)
Previous Article in Journal
Purification and Characterization of a Novel ~18 kDa Antioxidant Protein from Ginkgo biloba Seeds
Previous Article in Special Issue
New Triterpenes from Maytenus robusta: Structural Elucidation Based on NMR Experimental Data and Theoretical Calculations
Open AccessArticle

Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer

1
Department of General Surgery, Henry Ford Health System, Detroit, MI 48202, USA
2
Department of Radiology, Henry Ford Health System, Detroit, MI 48202, USA
*
Author to whom correspondence should be addressed.
Molecules 2012, 17(12), 14795-14809; https://doi.org/10.3390/molecules171214795
Received: 9 November 2012 / Revised: 20 November 2012 / Accepted: 6 December 2012 / Published: 11 December 2012
(This article belongs to the Special Issue Triterpenes and Triterpenoids 2013)
Methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate (CDDO-Me) is an synthetic oleanane triterpenoid with strong antiprolifertive and proapoptotic activities in cancer cells. However, the effect of CDDO-Me on human telomerase reverse transcriptase (hTERT) and its telomerase activity in prostate cancer cells has not been studied. We investigated the role of hTERT in mediating the anticancer activity of CDDO-Me in prostate cancer cells in vitro and in vivo. The inhibition of cell proliferation and induction of apoptosis by CDDO-Me in LNCaP and PC-3 prostate cancer cell lines was associated with the inhibition of hTERT gene expression, hTERT telomerase activity and a number of proteins that regulate hTERT transcriptionally and post-translationally. Furthermore, ablation of hTERT protein increased the sensitivity of cancer cells to CDDO-Me, whereas its overexpression rendered them resistant to CDDO-Me. In addition, inhibition of progression of preneoplastic lesions (i.e., low and high-grade prostate intraepithelial neoplasms, PINs) to adenocarcinoma of the prostate by CDDO-Me in TRAMP mice was associated with significant decrease in TERT and its regulatory proteins in the prostate gland. These data provide evidence that telomerase is a potential target of CDDO-Me for the prevention and treatment of prostate cancer. View Full-Text
Keywords: CDDO-Me; hTERT; telomerase activity; apoptosis; prostate cancer CDDO-Me; hTERT; telomerase activity; apoptosis; prostate cancer
Show Figures

Figure 1

MDPI and ACS Style

Liu, Y.; Gao, X.; Deeb, D.; Arbab, A.S.; Gautam, S.C. Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer. Molecules 2012, 17, 14795-14809.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop